dr. mehta on the evolution of treatment in gastric and gej cancers
Published 3 years ago • 131 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:29
dr. mehta on immunotherapy in gastric/gej cancer
-
0:58
dr. mehta on the role of biomarkers in gastric cancer
-
1:34
dr. mehta on the current treatment paradigm in her2-positive gastric cancer
-
1:43
dr. mehta on recent progress made in advanced gastric cancer
-
1:18
dr. mehta on rationale for a phase ii trial of tas-102/ramucirumab in gastric/gej cancer
-
6:50
upfront therapy approaches in gastric/gej cancer
-
5:42
evolving global treatment landscape for gastric cancer
-
8:00
hope for cancer patients: liver transplant for colorectal liver metastasis - transmet trial
-
59:06
gastric and gej cancers: treatment planning and sequencing in the era of immunotherapy
-
1:54
dr. janjigian on updated results from the destiny-gastric01 trial in her2 gastric cancer
-
1:55
dr. ku on combinations and sequencing of treatments for gastric cancer
-
7:26
is frontline io therapy appropriate in gastric cancer?
-
5:16
goals of therapy in metastatic gastric/gej cancer
-
5:34
metastatic gastric cancer: identifying disease progression
-
1:04
dr. ilson on the utility of zolbetuximab in claudin-positive gastric cancers
-
0:31
role of immunotherapy in gastric cancers
-
4:49
emerging nivolumab strategies in gastric/gej cancers
-
1:16
dr. ott on the checkmate-032 study in gastric and gej cancer
-
1:21
dr. shah on the rationale for the keynote-590 trial in esophageal carcinoma